Glycyrrhizinate dipotassium

甘草酸二钾

Report date: 2023/01/13 20:00:32
NME

Base Information

Drug NameGlycyrrhizinate dipotassium
Drug Alias NameDipotassium GlycyrrhizinateNeubormitin
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCorticosteroid 11-beta-dehydrogenase isozyme 1 inhibitors
TargetsCorticosteroid 11-beta-dehydrogenase isozyme 1
Therapy Area/IndicationsConjunctivitis, Allergic
Global Approved IndicationsConjunctivitis, Allergic
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved DateN/A
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSanten
China Registration ClassN/A

Develop Information

Active CompaniesSanten
Inactive CompaniesN/A
Active IndicationsConjunctivitis, Allergic
Inactive IndicationsN/A

Other Information

ATC CodeS01GX
Related LinksDrugBankKEGG